Connection

Bikash Medhi to Hydroxychloroquine

Back to Details
This is a "connection" page, showing publications Bikash Medhi has written about Hydroxychloroquine.
Bikash Medhi
Connection Strength
0.715
Hydroxychloroquine
  1. Folic acid as placebo in controlled clinical trials of hydroxychloroquine prophylaxis in COVID-19: Is it scientifically justifiable? Med Hypotheses. 2021 Apr; 149:110539.
    View in: PubMed
    Score: 0.163
  2. Post-exposure prophylaxis with hydroxychloroquine for the prevention of COVID-19, a myth or a reality? The PEP-CQ Study. Int J Antimicrob Agents. 2020 Dec; 56(6):106224.
    View in: PubMed
    Score: 0.160
  3. Coronavirus Disease-2019 Pandemic: Hopes Ride High on Targeting Known Drugs against Unkown. Indian J Pharmacol. 2020 Mar-Apr; 52(2):75-78.
    View in: PubMed
    Score: 0.155
  4. Virological and clinical cure in COVID-19 patients treated with hydroxychloroquine: A systematic review and meta-analysis. J Med Virol. 2020 07; 92(7):776-785.
    View in: PubMed
    Score: 0.154
  5. Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19. Ann Intern Med. 2021 03; 174(3):434.
    View in: PubMed
    Score: 0.041
  6. Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis. Indian J Med Res. 2021 Jan & Feb; 153(1 & 2):219-226.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.